» Articles » PMID: 22562815

Glioma Cells Promote the Expression of Vascular Cell Adhesion Molecule-1 on Bone Marrow-derived Mesenchymal Stem Cells: a Possible Mechanism for Their Tropism Toward Gliomas

Overview
Journal J Mol Neurosci
Date 2012 May 8
PMID 22562815
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The tropism of bone marrow-derived mesenchymal stem cells (BMSCs) toward gliomas has been shown by in vitro and in vivo assays. This study was carried out to evaluate the role of vascular cell adhesion molecule-1 (VCAM-1) in the migration of BMSCs towards glioma and the effect of glioma cells on the VCAM-1 expression of BMSCs. BMSCs were isolated according to their adherence to plastic. The tropism of BMSCs toward C6 and U87 glioma and the role of VCAM-1 in this migration were analyzed by in vitro migration assay, separately. Reverse transcription-polymerase chain reaction, immunofluorescence, and Western blot were employed to assess VCAM-1 expression of BMSCs when they were incubated by the conditioned mediums (CM) of C6 or U87 glioma cells. Data revealed that C6 and U87 glioma cells promote the migration of BMSCs, which could be blocked by a VCAM-1-neutralizing antibody. Moreover, VCAM-1 expression of BMSCs was elevated by the incubation of their CM. The results also demonstrated that LY294002, an inhibitor of phosphoinositide-3-kinase (PI3K), significantly inhibited the glioma-induced upregulation of VCAM-1 on BMSCs. These findings suggested that glioma-induced change in VCAM-1 expression of BMSCs may play an important role in their tropism towards glioma, and PI3K is associated with the signal transduction of this process.

Citing Articles

Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer.

Dalmizrak A, Dalmizrak O Front Bioeng Biotechnol. 2022; 10:956563.

PMID: 36225602 PMC: 9548561. DOI: 10.3389/fbioe.2022.956563.


Stem cells: a promising candidate to treat neurological disorders.

Song C, Zhang Y, Wu H, Cao X, Guo C, Li Y Neural Regen Res. 2018; 13(7):1294-1304.

PMID: 30028342 PMC: 6065243. DOI: 10.4103/1673-5374.235085.


Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.

Hill B, Pelagalli A, Passaro N, Zannetti A Oncotarget. 2017; 8(42):73296-73311.

PMID: 29069870 PMC: 5641213. DOI: 10.18632/oncotarget.20265.


Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?.

OMalley G, Heijltjes M, Houston A, Rani S, Ritter T, Egan L Oncotarget. 2016; 7(37):60752-60774.

PMID: 27542276 PMC: 5312417. DOI: 10.18632/oncotarget.11354.


CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma.

Yin Q, Zhou Y, Wang P, Ma L, Li P, Wang X Oncol Lett. 2016; 11(4):2353-2358.

PMID: 27073479 PMC: 4812259. DOI: 10.3892/ol.2016.4270.


References
1.
Yoo J, Haseley A, Bratasz A, Chiocca E, Zhang J, Powell K . Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus. Mol Ther. 2011; 20(2):287-97. PMC: 3277242. DOI: 10.1038/mt.2011.208. View

2.
Sasportas L, Kasmieh R, Wakimoto H, Hingtgen S, van de Water J, Mohapatra G . Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci U S A. 2009; 106(12):4822-7. PMC: 2660771. DOI: 10.1073/pnas.0806647106. View

3.
Aboody K, Brown A, Rainov N, Bower K, Liu S, Yang W . Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A. 2000; 97(23):12846-51. PMC: 18852. DOI: 10.1073/pnas.97.23.12846. View

4.
Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V . Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells. 2005; 24(1):23-33. DOI: 10.1634/stemcells.2004-0176. View

5.
Lau C, Koty Z, Nalbantoglu J . Differential response of glioma cells to FOXO1-directed therapy. Cancer Res. 2009; 69(13):5433-40. DOI: 10.1158/0008-5472.CAN-08-4540. View